Synthetic lipopeptides based on bacterial lipoprotein are ef®cient activators for monocytes/ macrophages inducing the release of interleukin (IL)-1, IL-6, tumour necrosis factor-a (TNF-a), reactive oxygen/nitrogen intermediates, and the translocation of nuclear factor kB (NFkB). In this report we investigate the signal transduction pathways involved in leucocyte activation by the synthetic lipopeptide N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)3-lysine (P 3 CSK 4 ). We show that P 3 CSK 4 activates mitogen-activated protein (MAP)-kinases ERK1/2 and MAP kinase (MAPK)-kinases MEK1/2 in bone-marrow-derived macrophages (BMDM) and in the macrophage cell line RAW 264 . 7. Additionally, we could detect differences between the P 3 CSK 4 and lipopolysaccharide (LPS)-induced phosphorylation of MAP kinases: Different levels in phosphorylation were found both in kinetics and dose±response using RAW 264 . 7 cells or BMDM from BALB/c and LPS responder mice (C57BL/10ScSn) or LPS nonresponder mice (C57BL/10ScCr). The lipopeptide activated the MAPK-signalling cascade in both LPS responder and non-responder macrophages, whereas LPS induced the MAPK signalling pathway only in macrophages derived from LPS responder mice. An approximately 70% decrease of lipopeptide induced NFkB translocation and an about 50% reduction of nitric oxide (NO) release was observed in the presence of anti-CD14. These data correspond to the reduction of phosphorylation of ERK1/2 after stimulation with P 3 CSK 4 in the presence of anti-CD14 antibodies. Inhibition of MEK1/2 by PD98059 completely reduced the lipopeptide-induced phosphorylation of ERK1/2 indicating that MEK1/2 are solely responsible for the phosphorylation of the downstream-located MAP kinases ERK1/2.
INTRODUCTION
Synthetic lipopeptides derived from bacterial lipoprotein constitute potent B-lymphocyte and macrophage/monocyte activators in vitro 1±3 inducing the release of a broad range of cytokines and reactive oxygen and nitrogen intermediates. In vivo they function as immunoadjuvants in parenteral, nasal and oral immunization either in combination or after covalent linkage with antigens, non-or low immunogenic substances or toxins. 4±8 Synthetic lipopeptides are well de®ned and can be synthesized easily and reproducibly 9±11 in large amounts under quality assurance conditions. They are exhibiting an excellent purity, lack of toxicity, and long-term stability and can substitute for Freund's adjuvant with respect to ef®ciency; they lack side-effects and in¯ammatory reactions. 7, 12, 13 Recent investigations indicate that lipopeptides bind to distinct membrane-localized compounds (Toll-like receptor (TLR)2, CD14); 14, 15 on the other hand they are, within minutes, distributed throughout the cell including the nucleus. 16 This suggests two modes of action: a direct in¯uence by targeting the nucleus which is favoured by`built in' nuclear localization sequences, and binding to distinct membrane compounds leading to the induction of signal transduction pathways similar as known for lipopolysaccharide (LPS). We focused our studies on the effect of lipopeptides on the mitogenactivated protein (MAP) kinase cascades. Until now, ®ve distinct evolutionary conserved MAP kinase signalling cascades have been identi®ed. These pathways include the mitogenic ERK1/2 cascade, 17 the stress activated JNK and p38 MAP kinase cascades, 18 and the ERK3 and ERK5 pathways. All MAP kinase pathways are organized in a conserved three-kinase architecture consisting of a MAP kinase, a MAP kinase kinase (MAP kinase activator), and a MAP kinase kinase kinase which activates the MAP kinase activator. 19 As the ERK1/2 cascade 17 plays a signi®cant role in mitogenesis, differentiation, cellular transformation, regulation of cell motility, and further cellular events 20±29 we studied the in¯uence of N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)3-lysine (P 3 CSK 4 ) on this signal transduction pathway. Our results indicate (1) the activation of the ERK1/ERK2 signalling pathway by the lipopeptide and (2) clear differences between LPS and P 3 CSK 4 with respect to the induction of the ERK1/ERK2 signal transduction pathway by using macrophages derived from LPS responder and non-responder mice. In addition our investigations clearly indicate that P 3 CSK 4 -dependent nitric oxide (NO) induction and nuclear factor kB (NFkB) translocation is due to a CD14-dependent process.
MATERIALS AND METHODS:
Reagents Anti-CD14 polyclonal antibody (CD14 (M-20): sc-6999) was purchased from Santa Cruz Biotechnology, Inc., CA; P 3 CSK 4 was prepared by chemical synthesis as described previously 10 and was obtained from EMC, Tu È bingen, Germany. LPS from Salmonella abortus equi was a kind gift from C. Galanos, Freiburg, Germany.
Mice
Six to 10-week-old BALB/c, C57BL/10 ScCr, and C57BL/10 ScSn mice were obtained from the breeding facilities of the Max-Planck-Institut fu È r Immunbiologie, Freiburg, Germany.
Macrophage cell lines
The murine macrophage cell line RAW 264 . 7 was cultured in Petri dishes (Falcon, Becton Dickinson, Heidelberg, Germany) in cRPMI-1640 media (RPMI-1640 containing 10% heat inactivated fetal calf serum (FCS), 1% non-essential amino acids (NEAA), 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 . 5 g/l glucose) at 37u and 5% CO 2 .
Bone-marrow-derived macrophages (BMDM) BMDM were differentiated in vitro from bone marrow precursor cells as described by Hoffmann et al. 30 Brie¯y, bone marrow cells were¯ushed from femurs and tibia of 6±10-weekold mice, washed twice in RPMI-1640 and grown for 17 days in liquid cultures in Te¯on ®lm bags (SLG, Gauting, Germany) at 37u and 5% CO 2 . The culture medium consisted of RPMI-1640 supplemented with 15% L-cell-conditioned medium as a source of macrophage colony-stimulating factor (M-CSF), 10% heat inactivated FCS, 5% heat inactivated horse serum, 1 mM sodium pyruvate (both from Seromed Biochrom KG, Germany), 50 U/ml penicillin, 50 mg/ml streptomycin, and 5r10 x5 M mercaptoethanol. Cultures were set up with 6r10 6 cells/50 ml. After harvesting, the macrophages were washed once, counted and resuspended at 2r10 6 cells/ml. For the preparation of L-cell-conditioned medium, 1r10 5 L929 cells/ml were cultured in 100 ml-batches in cell culturē asks (Falcon, Becton Dickinson) in cRPMI-1640 at 37u and 5% CO 2 . After 7 days, the culture supernatants were harvested, cleared from cell debris by centrifugation (1500 g, 4u, 15 min) and stored at x20u.
Induction and determination of NO release in BMDM and the macrophage cell line RAW 264 . 7 BMDM and RAW 264 . 7 were harvested, washed once and resuspended in RPMI-1640 medium. 1r10 5 cells/well were seeded into 96-well¯at bottom microtitre plates (Falcon, Becton Dickinson) and stimulated with different concentrations of P 3 CSK 4 or LPS in a total volume of 150 ml. Culture supernatants were harvested after 48 hr (BMDM) or 24 hr (RAW 264 . 7). All assays were performed in triplicate. Production of NO was determined by measuring nitrite, a stable metabolite of NO, in the culture supernatants using the Griess reaction. 31 Accordingly, 100 ml culture supernatant were mixed with 100 ml Griess reagent (1% sulphanilamide and 0,1% N-(1-naphtyl)ethylendiamine in 2,5% phosphoric acid), and the absorbance at 550 nm was monitored with a Dynatec MRX enzyme-linked immunosorbent assay (ELISA) plate reader (Dynatec, Denkendorf, Germany). Nitrite concentrations were calculated by using sodium nitrite as a standard.
Stimulation of BMDM and macrophage cell lines and preparation of cellular extracts Seventeen-day-old BMDM, or RAW 264 . 7 cells (1r10 6 ), were seeded into the wells of 24-well-plates in RPMI-1640 with NEAA and antibiotics, incubated overnight and then stimulated with various concentrations of P 3 CSK 4 or LPS for different periods of time. The plates were placed on ice, the medium was replaced by 100 ml/well lysis buffer (62 . 5 mM tris(hydroxymethyl)aminomethane/HCl, pH 6 . 8, containing 10 mM dithiothreitol, 2 . 5% sodiumdodecyl sulphate, 1 mM Na 3 VO 4 , 50 mM NaF, 0 . 05% bromophenol blue, one protease-inhibitor-cocktail pill/10 ml (Boehringer Mannheim, Germany), 7 . 4 mM tris(hydroxymethyl)aminomethane, 0 . 06 mM glycine, and 15 . 5 mM glycerol). The cell lysate was removed with a syringe, placed in a reaction vial, incubated at 95u for 5 min, centrifuged (30 s, 13 250 g.) and stored frozen at x70u.
Polyacrylamide gel electrophoresis and Western blotting Polyacrylamide gel electrophoresis was performed according to Laemmli 32 using 10% resolution gels with 5% stacking gels. Transfer of the separated samples onto a polyvinylidenē uoride (PVDF) transfer membrane (Hybond-P, RPN303F, Amersham, Germany) was performed with a Mini-Protean II system (BioRad, Mu È nchen, Germany). PVDF membranes were blocked overnight at 4u in blocking buffer (20 mM tris(hydroxymethyl)aminomethane/HCl, pH 7 . 6, containing 0 . 5 M NaCl, 0 . 05% Tween-20, and 5% skimmed milk powder) and then incubated for 1 hr at room temperature in blocking buffer containing antiphospho-p44/42 MAP kinase E10 monoclonal antibody (New England BioLabs, Beverly, MA) or antiphospho MEK1/2 kinase antibody (New England BioLabs). After washing three times with TTBS (20 mM tris(hydroxymethyl)aminomethane/HCl, pH 7 . 6, containing 0 . 5 M NaCl and 0 . 05% Tween-20), the membranes were incubated in blocking buffer with horseradish peroxidase (HRP)-conjugated second antibodies for 1 . 5 hr at room temperature (rabbit anti-mouse immunoglobulin G (IgG) peroxidase conjugated, Tago, CA/goat anti-rabbit immunoglobulin peroxidase conjugated; Dako, Denmark). After washing three times with TTBS and once with Tris-buffered saline (TBS; 20 mM tris(hydroxymethyl)aminomethane/HCl, pH 7 . 6, containing 0 . 5 M NaCl and 0 . 05% Tween-20), bound antibodies were detected using the ECL+ Plus Western Blotting Detection System (Amersham Pharmacia Biotech, Germany).
Stimulation of cells and analysis of NFkB translocation
Indirect immuno¯uorescence analyses were performed as previously described. 33 BMDM of BALB/c mice were seeded into an eight-well glass slide (Nunc, Denmark) at a concentration of 2 . 5r10 4 cells/well and allowed to grow to about 70% con¯uency. Cells were washed with phosphate-buffered saline (PBS) and ®xed in 3 . 5% paraformaldehyde/PBS for 15 min at room temperature. Cells were permeabilized in PBS containing 0 . 5% saponin, 0 . 2% BSA, 2% FCS, and 5 mM MgCl 2 for 10 min. All further washes and incubations were carried out in the same solution containing 0 . 05% saponin. After ®xation and permeabilization, cells were washed three times for 3 min with constant gentle agitation. For detection of NFkB, cells were incubated for 2 hr with an anti-NFkB antibody (rabbit polyclonal IgG, NFkB p65, SC-109, Santa Cruz Biotechnology, Santa Cruz, CA) at a 1 : 40 dilution. Subsequently, cells were washed 5r3 min, followed by addition of the secondary antibody (goat anti-rabbit IgG, biotin-conjugated, Sigma, Deisenhofen, Germany), diluted 1 : 50 and incubated for 2 hr at room temperature. Fluoroscein isothiocyanate (FITC)-labelled avidin (Sigma), diluted 1 : 50, was added and the cells were further incubated for 2 hr in the dark. Cells were washed 6r3 min with occasional agitation at room temperature and then examined under a¯uorescence microscope (Polyvar, Reichert-Jung, Jena, Germany).
RESULTS

Induction of MAP kinase phosphorylation by P 3 CSK 4
The activation of MAP kinases (p42/44) requiring phosphorylation at threonine and tyrosine was monitored by immunoblot analysis using anti-phospho-speci®c MAP kinase antibodies. Stimulation with P 3 CSK 4 of the macrophage cell line RAW 264 . 7 or of BMDM from BALB/c mice resulted in a dose-dependent modulation of phosphorylation of the MAP kinases ERK1 and ERK2. As shown in Fig. 1 led to an increased phosphorylation of MAP kinases ERK1/2, when using concentrations in the range of 10±100 mg/ml. Similar results were obtained with BMDM from BALB/c mice when stimulated with P 3 CSK 4 in the concentration range of 5±100 mg/ml (Fig. 1b) . Lower P 3 CSK 4 concentrations (0 . 1±1 . 0 mg/ml) showed no increase in phosphorylation after 15 min, followed by a slight increase after 30, 60±90 min only for RAW 264 . 7 cells (Fig. 1a) . In BMDM from BALB/c mice low P 3 CSK 4 concentrations (0 . 1±1 . 0 mg/ml) had a similar effect (Fig. 1b) . When stimulating cells with high P 3 CSK 4 concentrations (5±100 mg/ml) we observed a rapid decrease of the high phosphorylation level found after 15 min with time with respect to both cell lines (Fig. 1a, b) . In contrast, stimulation with LPS, which is known to activate both MAP kinases, led to a dose-and stimulation time-dependent steady increase in phosphorylation: from 1 to 10 mg/ml LPS and/or from short (15 min) to longer (90 and 60 min) stimulation time intervals an increased phosphorylation of ERK1 and ERK2 was detected in RAW 264 . 7 cells and BMDM (Fig. 1a, b) . Figure 2 shows the kinetics of the P 3 CSK 4 induced phosphorylation of the MAP kinases using two lipopeptide concentrations (5 and 10 mg/ml). P 3 CSK 4 -induced MAP kinase phosphorylation was already detected after 5 min, increased to a maximum at 30 min (5 mg/ml P 3 CSK 4 ) or at 15±60 min (10 mg/ml P 3 CSK 4 ), before decreasing to lower levels by 90 min. In contrast, LPS (10 mg/ml) induced a low signal at 15 min, and a more pronounced signal at 90 min indicating different activation processes of ERK1/2 with respect to LPS and P 3 CSK 4 .
Induction of MAPK kinase phosphorylation by P 3 CSK 4
Activation of the upstream MAP kinase regulator proteins MEK1 and MEK2 (MAPK kinases) occurs through phosphorylation of two serine residues at position 217 and 221. Therefore, an anti-phospho-MEK antibody was used for monitoring by immunoblot analysis the MEK1/2 activation stage; this antibody selectively recognizes activated, phosphorylated MEK1/2. As shown in Fig. 3 , incubation of RAW 264 . 7 cells with P 3 CSK 4 for 15, 30, and 60 min resulted in a dose-dependent increase of phosphorylation of MEK1 and MEK2. Again, as observed for ERK1/2, high amounts of P 3 CSK 4 (5±100 mg/ml) resulted already after short stimulation periods (15 min) in high phosphorylation levels; longer stimulation intervals (30±60 min) induced an increase of phosphorylation only at lower P 3 CSK 4 concentrations (0 . 5±1 mg/ml) but lead to a decrease of phosphorylation at higher concentrations. In contrast, stimulation with LPS showed a dose-and time-dependent steady increase in activation of both MEK1 and MEK2 (Fig. 3a±c, lanes 9 and 10) . All samples used to detect phosphorylation contained a comparable amount of MEK1 and MEK2 (Fig. 3d) , indicating that the detected differences in phosphorylation are not caused by different protein levels of MEK1 and MEK2, and suggesting that lipopeptide and LPS are not inducing de novo MEK1 and MEK2 protein expression. P 3 CSK 4 and LPS are thus inducing different levels of phosphorylation suggesting different signal transduction mechanisms for both compounds with respect to macrophages.
Induction of MAP kinase phosphorylation in BMDM from LPS responder/LPS non-responder mice
Mutation of TLR4 in mice of the strain C57BL/10ScCr impedes LPS-induced signal transduction preventing the response to LPS. Animals of the control strain C57BL/10ScSn are normally responsive. 34 In order to further elucidate the signal transduction mechanisms induced by P 3 CSK 4 and to detect possible differences to LPS stimulation, BMDM derived from LPS responder and non-responder mice were stimulated with both compounds and monitored for ERK1 and ERK2 activation. As can be seen in Fig. 4(a) , cells of the LPS responder strain C57BL/10ScSn showed a strong, dosedependent activation of the MAP kinases ERK1 and ERK2 following P 3 CSK 4 and LPS stimulation. Figure 4 (a, upper panel) represents the MAP kinase phosphorylation patterns obtained after a 30-min stimulation with P 3 CSK 4 (0 . 1, 0 . 5, 1, 5, 10, and 100 mg/ml) or LPS (1 and 10 mg/ml). MAP kinase activation started when stimulated for 30 min at 0 . 5 mg/ml P 3 CSK 4 , reached an optimum at 5 and 10 mg/ml P 3 CSK 4 and decreased to lower phosphorylation levels at 100 mg/ml P 3 CSK 4 ; no activation was observed following stimulation with 0 . 1 mg/ml P 3 CSK 4 and in control cells. Sixty-minute stimulation periods (Fig. 4a, lower panel) resulted in a shift of the above observed phosphorylation pattern to lower P 3 CSK 4 concentrations: MAP kinase activation started at 0 . 1 mg/ml P 3 CSK 4 , reached an optimum at 0 . 5 and 1 mg/ml P 3 CSK 4 and decreased to lower phosphorylation levels over 5, 10±100 mg/ml P 3 CSK 4 . With respect to LPS, a strong phosphorylation was detected at 10 mg/ml (30 min stimulation), which was comparable to that obtained after stimulation (30 min) with 10 mg/ml P 3 CSK 4 . Stimulation of C57BL/10ScSn cells with 1 mg/ml LPS for 30 min resulted in an activation of MAP kinase which reached about 1/10 of that observed after stimulation using 10 mg/ml LPS. MAP kinase phosphorylation levels increased from 30 min to 60 min stimulation periods when using 1 mg/ml LPS but decreased for about 50% when stimulating the cells for 60 min with 10 mg/ml LPS (compared to a stimulation period of 30 min). Incubation of BMDM prepared from the LPS non-responder strain C57BL/10 ScCr with P 3 CSK 4 resulted in activation patterns comparable to the responder strain (Fig. 4b) . In contrast, incubation with LPS induced no phosphorylation of ERK1 and ERK2 at concentrations of 1 mg/ml, and the phosphorylation levels after 30 and 60 min stimulation periods were drastically reduced when using 10 mg/ml LPS (Fig. 4b, upper and lower panel) . Our results clearly indicate different signal transduction mechanisms for P 3 CSK 4 and LPS.
Induction of NFkB translocation in BMDM derived from LPS responder/LPS non-responder and BALB/c mice and in RAW 264 . 7 cells Stimulation of BMDM from LPS non-responder mice (C57BL/ 10ScCr) with P 3 CSK 4 resulted in translocation of NFkB into the cell nucleus (Fig. 5a, left panel) , which corresponds to the observed ERK1/2 and MEK1/2 phosphorylation. In contrast, LPS-stimulation of BMDM from LPS non-responder mice did not induce translocation of p65 NFkB into the cell nucleus (Fig. 5a, middle panel) corresponding again to the observed lack of phosphorylation of ERK1/2 and MEK1/2. BMDM from LPS responder mice, however, after P 3 CSK 4 or LPS stimulation showed a translocation of p65 NFkB into the nucleus (Fig. 5b, left and middle panels) . These different effects of P 3 CSK 4 and LPS in LPS responder and non-responder mice indicate that the P 3 CSK 4 -induced signalling pathway is, in contrast to the LPS-activation, TLR4 independent.
Analysis of the subcellular distribution of the p65 NFkB in RAW 264 . 7 cells after stimulation of the cells with P 3 CSK 4 (b) (a) Figure 4 . Induction of MAP kinase (ERK1/2) phosphorylation of P 3 CSK 4 -and LPS-stimulated BMDM from C57 BL/10 ScSn (a) and C57 BL/10 ScCr mice (b). (a) BMDM from C57 BL/10 ScSn (LPS responder) mice were stimulated for 30 and 60 min with the indicated amounts of P 3 CSK 4 and LPS and the induced phosphorylation of the MAP kinases ERK1 and ERK2 was monitored by Western blot using phospho-p44/42 MAP kinase E10 monoclonal antibodies. Bands were visualized by the enhanced chemiluminescence method as described in Materials and Methods. (b) BMDM from C57 BL/10 ScCr (LPS nonresponder) mice were stimulated for 30 and 60 min with the indicated amounts of P 3 CSK 4 and LPS. The resulting MAP kinase phosphorylation was detected as described under (a). C represents resting, unstimulated cells (control).
(1 mg/ml) for 2 hr resulted in NFkB translocation into the nucleus (Fig. 6a, left panel) ; similar results were obtained after treatment with LPS (1 mg/ml) which was used as a positive control (Fig. 6a, middle panel) . No NFkB translocation was observed in non-treated control cells (Fig. 6a, right panel) . Analysis of the subcellular distribution of the p65 NFkB in BMDM derived from the LPS responder BALB/c mice resulted after treatment of the cells with P 3 CSK 4 (1 mg/ml) for 2 hr in NFkB translocation into the nucleus (Fig. 6b, left panel) ; similar results were obtained after stimulation with LPS (1 mg/ ml), which was used as a positive control (Fig. 6b, middle  panel) . No NFkB translocation was observed in control cells (Fig. 6b, right panel) .
Induction of NO release by P 3 CSK 4 and LPS in BMDM derived from LPS responder/LPS non-responder and BALB/c mice, and in RAW 264 . 7 cells
We examined the release of NO from the macrophage cell line RAW 264 . 7 and BMDM from BALB/c mice after stimulation with P 3 CSK 4 . Cells were stimulated for 24 hr (RAW 264 . 7) or 48 hr (BMDM), subsequently the culture supernatants were monitored for nitrite contents. As shown in Fig. 7 , P 3 CSK 4 induced the release of NO in a dose-dependent manner in both, RAW 264 . 7 cells (Fig. 7a) and BMDM from BALB/c mice (Fig. 7b) . A similar dose±response-dependent induction of NO release was observed for both cell lines after stimulation with LPS (Fig. 7a, b, inserts) . No induction of NO release was observed when stimuli were omitted. BMDM prepared from both, LPS responder (C57BL/ 10ScSn) and LPS non-responder (C57BL/10ScCr) mice released comparable quantities of NO after stimulation with P 3 CSK 4 ( Fig. 7c, d ). In addition, the kinetics of P 3 CSK 4 -induced NO production were comparable in BMDM prepared from C57BL/10ScSn and C57BL/10ScCr animals (data not shown). Corresponding to the lacking ERK1/2/MEK1/2 phosphorylation and NFkB translocation, BMDM prepared from the C57BL/10ScCr mice (LPS non-responder) were not able to respond to LPS-stimulation. No induction of NO release was detected after a 48-hr stimulation period with LPS (Fig. 7c, insert) . In contrast, BMDM derived from closely related C57BL/10ScSn mice (LPS responder) showed a strong enhancement of NO release after LPS stimulation for 48 hr (Fig. 7d, insert) , which was similar to that observed with BMDM derived from BALB/c mice also containing an intact TLR4 receptor (Fig. 7b, insert) .
Inhibition of P 3 CSK 4 -and LPS-dependent induction of NO release in BMDM by anti-CD14-directed antibodies
LPS-induced NO release was inhibited by about 50% when stimulation was performed in the presence of anti-CD14-directed antibodies (Fig. 8a, lower panel) . This 50% inhibition was observed for all tested LPS concentrations (1, 0 . 1, and 0 . 01 mg/ ml). Later, at all used LPS concentrations, no induction of NO release was monitored when the stimulation was performed in the presence of the NFkB inhibitor PDTC. No induction was detected in the presence of media (control); an about 10 mM NO release was observed in the presence of anti-CD14 antibodies alone. For P 3 CSK 4 , a similar inhibitory effect (< 50%) ± as seen with LPS ± was obtained when stimulation was performed in the presence of anti-CD14-directed antibodies. Again, as also seen with LPS, complete inhibition was detected when P 3 CSK 4 stimulation was performed in the presence of PDTC (Fig. 8a, upper panel) . CD14-non-related antibodies showed no inhibitory effect on LPS-and P 3 CSK 4 -dependent NO release (data not shown).
Inhibition of P 3 CSK 4 -and LPS-dependent NFkB tranlocation in BMDM from BALB/c mice by anti-CD14-directed antibodies
Inhibition experiments using anti-CD14-directed antibodies resulted in an about 70% reduction of NFkB translocation when cells were stimulated with 1 mg/ml P 3 CSK 4 (Fig. 8b) .
With LPS an approximately 30% inhibition of translocation was detected in the presence of anti-CD14 antibodies. No translocation was found in control cultures containing media or in the presence of antibodies.
Inhibition of P 3 CSK 4 -dependent ERK1/2 phosphorylation in BMDM from BALB/c mice by anti-CD14-directed antibodies and PD98059
Lipopeptide-induced ERK1/2 phosphorylation was inhibited by about 40% when cells were stimulated with lipopeptide for 30 min in the presence of anti-CD14-directed antibodies (Fig. 8c, lanes 2 and 3) . With respect to LPS-induced ERK1/ 2 phosphorylation, incubation of the cells in the presence of anti-CD14-directed antibodies resulted in a signi®cant weaker inhibition (data not shown). Lipopeptide-induced ERK1/2 phosphorylation was completely reduced in the presence of PD98059, a speci®c inhibitor of the upstream located kinases MEK1/2 (Fig. 8c, lanes 4 and 5) . In contrast, lipopeptide stimulation was not inhibited by PDTC, a NFkB inhibitor (Fig. 8c, lane 6) . No phosphorylation was observed in the control containing media (Fig. 8c, lane 1) and in the presence of PDTC (Fig. 8c, lane 10 ).
DISCUSSION
P 3 CSK 4 , a synthetic lipopeptide derived from bacterial lipoprotein, has shown to be an effective immunoadjuvant in parenteral, nasal and oral immunization. 4±8 In vitro P 3 CSK 4 constitutes a potent macrophage/monocyte activator resulting in the induction of lymphokine production, phagocytosis, activation for tumour cytotoxicity, tumour necrosis factor-a (TNF-a) production, and release of reactive oxygen and nitrogen intermediates. 1, 3, 35 The focus of this study was to further elucidate the signalling mechanisms of P 3 CSK 4 -induced activation of macrophages. Because bacterial compounds such as LPS, lipoproteins of different sources and other bacterial cell-wall components are known to stimulate macrophages via activation of MAP kinases, 36±38 which are linked to the regulation and expression of cytokine genes as well as to other important cellular functions, we concentrated our (a) RAW 264 . 7 cells were stimulated for 2 hr with either P 3 CSK 4 (1 mg/ml) or LPS (1 mg/ml). Subsequently, the cells were immunostained with anti-NFkB p65 antibodies. Bound antibodies were visualized by biotinylated goat anti-rabbit IgG and FITCconjugated avidin, as described in Materials and Methods. The control represents resting, unstimulated RAW 264 . 7 cells. (b) BMDM from BALB/c mice were stimulated for 2 hr with either P 3 CSK 4 (1 mg/ml) or LPS (1 mg/ml). The resulting NFkB translocation was monitored as described under (a). The control represents resting, unstimulated macrophages derived from the bone marrow of BALB/c mice.
investigations on the ability of P 3 CSK 4 to induce the ERK1/2 signal transduction pathway. We also monitored differences between P 3 CSK 4 -and LPS-induced activation. We checked the MAP kinase signalling pathway at different levels after LPS and P 3 CSK 4 stimulation measuring kinase phosphorylation (ERK1/2), kinase kinase phosphorylation (MEK1/2), NFkB translocation, and the induction of NO release. Determinations were performed in RAW 264 . 7 cells and BMDM from BALB/c, C57BL/10ScSn (LPS responder) and C57BL/10ScCr (LPS non-responder) mice. First, we observed differences in the kinetics of LPS-and lipopeptide-induced ERK1/2 and MEK1/2 phosphorylation. P 3 CSK 4 stimulation of RAW 264 . 7 cells or BMDM from BALB/c mice resulted in a strong dose-and time-dependent increase of ERK1/2 and MEK1/2 phosphorylation. In contrast, LPS, which is known to signal via CD14 and TLR4, resulted in a comparably weak increase of ERK1/2 and MEK1/ 2 phosphorylation in RAW 264 . 7, or in BMDM from BALB/c mice. The differences in the kinetics of P 3 CSK 4 -and LPSinduced ERK1/2 phosphorylation indicate the involvement of different signal transduction mechanisms and receptors for LPS and the synthetic lipopeptide P 3 CSK 4 . These results are in accordance with earlier investigations indicating that TLR2 makes no contribution to LPS signal transduction. Experiments monitoring the P 3 CSK 4 -and LPS-induced activation of the upstream MAP kinase regulator proteins (MAPK kinases) MEK1 and MEK2 revealed phosphorylation patterns corresponding to the ones observed for ERK1/2: Again, P 3 CSK 4 induced a strong phosphorylation after shorttime stimulation at high doses. In contrast, LPS-induced phosphorylation of MEK1/2 reached a late maximum at 90 min at high LPS concentrations. Control experiments showed that all samples taken after stimulation using different LPS or P 3 CSK 4 concentrations contained comparable amounts of 1EK1/2 suggesting no LPS-or P 3 CSK 4 -induced de novo synthesis. Thus, mainly the upstream MAPkinase kinases MEK1/2 are responsible for the phosphorylation of the kinases ERK1/2 after LPS and P 3 CSK 4 stimulation. Further, the differences in kinetics of LPS-and P 3 CSK 4 -induced phosphorylation of MEK1/2 and ERK1/2 strongly suggest different signalling transduction pathways for both bacterial compounds. These data are in accordance with earlier investigations reporting distinct pathways for LPS and lipoproteins from Treponema pallidum and Borrelia burgdorferi.
40
In order to monitor differences in the LPS and P 3 CSK 4 signalling pathway, we investigated BMDM derived from LPS responder and non-responder mice. A null mutation of TLR4 in mice of the strain C57BL/10ScCr impedes LPS-induced signal transduction, and therefore prevents a response to LPS. Animals of the control strain C57BL/10ScSn are normally responsive. 34 Stimulation of BMDM prepared from LPS responder mice (C57BL/10ScSn) showed an almost identical time-and dose-dependent pattern of ERK1/2 phosphorylation as observed for RAW 264 . 7 cells and BMDM derived from BALB/c mice, which all contain the intact TLR4. In contrast, BMDM prepared from LPS non-responder mice were not able to phosphorylate ERK1/2 after LPS stimulation, but still showed a dose-and time-dependent P 3 CSK 4 -induced phosphorylation pattern almost identical to that detected in BMDM obtained from LPS responder mice, BALB/c mice or RAW 264 . 7 cells. Our results clearly indicate that TLR4 plays no major role in the activation of macrophages by P 3 CSK 4 .
LPS and bacterial lipoproteins have been shown to stimulate the nuclear translocation factor NFkB, 15 ,40±42 which in turn upregulates the transcription of a number of genes whose products are involved in in¯ammation. 43 Because earlier investigations also suggested distinct signalling pathways for LPS and bacterial lipoproteins we investigated the LPS-and P 3 CSK 4 -induced translocation of NFkB in BMDM from LPS responder and non-responder mice. Analysing the subcellular distribution of p65 NFkB we could demonstrate that BMDM from both strains showed NFkB translocation when stimulated with P 3 CSK 4 . When stimulated with LPS, only the LPS responder cells showed NFkB translocation, whereas no NFkB-translocation was observed in BMDM derived from LPS non-responder mice. Our ®ndings clearly demonstrate that P 3 CSK 4 induces phosphorylation of ERK1/2 and MEK1/2 and the translocation of NFkB. Further on, the P 3 CSK 4 induced signal transduction is TLR4 independent. This is in agreement with prior studies reporting that murine TLR4 does not function analogously in LPS and bacterial lipoprotein signalling because a TLR4 mutation, which renders cells insensitive to LPS, does not abrogate bacterial lipoproteininduced responses. 34, 44, 45 LPS and P 3 CSK 4 activate nitric oxide synthase (NOS) in macrophages.
46±49 Accordingly, LPS and P 3 CSK 4 stimulation resulted in the induction of NO release in the macrophage cell line RAW 264 . 7, and in BMDM from BALB/c mice. Experiments with BMDM derived from LPS responder and non-responder strains showed a comparable dose-dependent P 3 CSK 4 -dependent NO release. In contrast, no release was detected in LPS non-responder cells after stimulation with LPS. The presence of PDTC, an inhibitor of NFkB-activation, almost completely reduced P 3 CSK 4 -induced NO release indicating that NFkB is the critical transcription factor for the upregulation of P 3 CSK 4 -induced inducible nitric oxide synthase (iNOS) expression; activation of the transcription factors AP-1, octamer binding protein-1, the cAMP response element-binding protein, and the promoter-selective transcription factor (Sp1) is not in¯uenced by PDTC. 50, 51 These results are in agreement with earlier investigations showing that the critical transcriptional factor in LPS-induced NO release is NFkB. 52 However, our investigations clearly indicate that LPS-and P 3 CSK 4 -induction of NFkB translocation are caused by different signalling transduction mechanisms. Accordingly, P 3 CSK 4 induced (in contrast to LPS) no ERK1/2 signal transduction, no NFkB translocation, and no induction of NO release in TLR2-de®cient BMDM prepared from TLR2 knockout mice (manuscript in preparation).
We also investigated the involvement of CD14 in lipopeptide-dependent activation of macrophages. We found that both NFkB translocation and induction of NO release was signi®cantly reduced when P 3 CSK 4 stimulation was performed in the presence of anti-CD14 antibodies. Accordingly, in the presence of anti-CD14 antibodies the NFkB translocation was inhibited by about 70%, and NO release was reduced by about 50%. These unexpected data strongly suggest the involvement of CD14 in the P 3 CSK 4 -induced dependent signal transduction mechanism. Finally, we observed an about 40% inhibition of the P 3 CSK 4 -dependent ERK1/2 phosphorylation by anti-CD14-directed antibodies, which clearly indicates that P 3 CSK 4 -dependent NFkB translocation and NO release is regulated via CD14.
In summary, the present studies indicate that the P 3 CSK 4 -dependent activation of macrophages is induced via phosphorylation of the MAP kinases ERK1/2 and MEK1/2 resulting in NFkB translocation and the induction of NO release. Further on, the P 3 CSK 4 -dependent signalling process is likely to be CD14/TLR2 dependent and TLR4 independent. Presently we are investigating if further genes are activated or otherwise modi®ed in their transcription ef®ciency in the P 3 CSK 4 -induced signal transduction pathway.
